Weighing a semaglutide care offer
Put a study result beside the claim.
A study result is a starting point for a conversation. Ask whether the people in that study resemble your situation and what the result actually measured.
Ask who took part
- Were the participants treating the same health problem as me?
- What support did they receive alongside the medicine?
Keep in mind STEP 1 studied adults without diabetes, a condition affecting blood sugar.
The participants had either obesity, meaning a substantial amount of excess body fat, or excess weight along with a related health condition.
Regular visits and guidance about daily habits were provided to both groups in the study; its funding came from Novo Nordisk, the semaglutide maker.
Read the medicine and comparison results together
- What was the average change?
- What happened in the comparison group?
Keep in mind Over 68 weeks in STEP 1, the semaglutide group lost an average of 14.9% of starting body weight.
The placebo group, given a dummy shot without the study medicine, lost an average of 2.4% over the same 68 weeks.
Ask what an average leaves unanswered
- How will we set a goal that fits my health?
- How would we review results and problems along the way?
Keep in mind These trial averages do not promise the same change for an individual person.
Use the result to ask a more specific question, rather than treating it as a forecast for yourself.